Clinton Health Access Initiative
Mbabane, Eswatini
NCT Number: NCT04183413
The WHO-PEN@Scale project is a three-arm cluster-randomized trial that is investigating the population-level effects of a healthcare reform in Eswatini, which aims to strengthen primary care for diabetes and hypertension. Prior to the reform, healthcare for diabetes and hypertension was mostly provided through physician-led teams in hospital outpatient departments. The healthcare reform aims to strengthen the provision of nurse-led care for diabetes and hypertension in primary healthcare facilities and community health worker-led care for these conditions in the facilities' catchment areas. The reform will broadly be guided by the World Health Organization's "Package of Essential Noncommunicable Disease Interventions for Primary Health Care in Low-Resource Settings" (WHO-PEN). The trial will take place at 84 clusters (a primary healthcare facility and its catchment area) across the country.
Looking for future studies?
Notify Me40 year and older
All sexes
Interventional
Not applicable
Mbabane, Eswatini
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
for the outcome assessment (household survey):
Exclusion criteria
for the outcome assessment (household survey):
This intervention consist of three Differentiated Service Delivery Models in which stable clients can be enrolled. The fast-track model gives preferential treatment to enrolled clients. Clients arrive at clinics, usually early in the morning, and can see the nurse as well as collect their medication without queuing. This model mainly targets the working population. The facility-based treatment clubs consist of bimonthly meetings where clients meet in groups of approximately 20 members. They receive health counselling, risk factor screening and medication prescription. This model mainly targets clients living close to the facility. The community advisory groups consist of groups of up to six clients. Groups are equipped with a point of care blood pressure and blood glucose measurement devices. They take turns in collecting the medication for the entire group and meet on a monthly basis. This model targets clients in hard-to-reach areas.
Community Distribution Points are set up on a monthly basis in communities linked to the clinic. Healthcare staff sets up a temporary point of contact where clients can obtain screening for diabetes and hypertension, health counselling, referral to primary or tertiary facilities, and medication.
Time frame: 12 months
Mean glycated haemoglobin (HbA1c) among adults aged 40 years and older with diabetes
Time frame: 12 months
Mean systolic blood pressure among adults aged 40 years and older with hypertension
Time frame: 12 months
Mean glycated haemoglobin (HbA1c) among adults aged 40 years and older with diabetes or prediabetes
Time frame: 12 months
The proportion of adults aged 40 years and older with diabetes who have an HbA1c less than 7.0%
Time frame: 12 months
The proportion of adults aged 40 years and older with diabetes or prediabetes who have an HbA1c less than 7.0%
Time frame: 12 months
The proportion of adults aged 40 years and older with diabetes who report to have been diagnosed with diabetes prior to the household survey
Time frame: 12 months
The proportion of adults aged 40 years and older with diabetes or prediabetes who report to have been diagnosed with diabetes or prediabetes prior to the household survey
Time frame: 12 months
The proportion of adults aged 40 years and older with diabetes who report to be taking medication for their diabetes
Time frame: 12 months
The proportion of adults aged 40 years and older with diabetes who report to have ever been tested for diabetes
Time frame: 12 months
The proportion of adults aged 40 years and older with diabetes or prediabetes who report to have ever been tested for diabetes
Time frame: 12 months
The proportion of adults aged 40 years and older with diabetes, prediabetes, or hypertension who report to be a current smoker
Time frame: 12 months
The mean number of minutes in a typical week spent doing moderate- or vigorous-intensity exercise among adults aged 40 years and older with diabetes
Time frame: 12 months
Mean systolic blood pressure among adults aged 40 years and older with diabetes
Time frame: 12 months
Mean systolic blood pressure among adults aged 40 years and older with diabetes or prediabetes
Time frame: 12 months
Mean diastolic blood pressure among adults aged 40 years and older with diabetes
Time frame: 12 months
Mean diastolic blood pressure among adults aged 40 years and older with diabetes or prediabetes
Time frame: 12 months
The proportion of adults aged 40 years and older with hypertension who have a systolic blood pressure <140 mm Hg and a diastolic blood pressure <90 mm Hg
Time frame: 12 months
Mean diastolic blood pressure among adults aged 40 years and older with hypertension
Time frame: 12 months
The proportion of adults aged 40 years and older with hypertension who report to have been diagnosed with hypertension prior to the household survey
Time frame: 12 months
The proportion of adults aged 40 years and older with hypertension who report to be taking blood-pressure-lowering medication
Time frame: 12 months
The proportion of adults aged 40 years and older with hypertension who report to have ever had their blood pressure measured
Time frame: 12 months
The proportion of adults aged 40 years and older with diabetes, prediabetes, or hypertension who report to having drunk daily, 5-6 days per week, 3-4 days per week, 1-2 days per week, 1-3 days per month, less than once a month, or never over the past 12 months.
Time frame: 12 months
The proportion of adults aged 40 years and older with diabetes, prediabetes, or hypertension who correctly responded to each individual question on diabetes and hypertension related knowledge.
University Hospital Heidelberg
Other
Strengthening Primary Healthcare Delivery for Diabetes and Hypertension in Eswatini: A Cluster-randomized Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03580330
Cardiovascular Diseases, Diabetes Mellitus
View Trial DetailsNCT06871293
COVID 19, COVID-19
Bogotá, Bogotá DC, Colombia
View Trial DetailsNCT05820295
Arrhythmias, Cardiac, Atrial Fibrillation
New York, United States
View Trial DetailsNCT05574699
Cardiovascular Diseases, Chronic Disease
Baltimore, Maryland, United States
View Trial Details